Abstract
Fluorine-18 (18F) is undoubtedly one of the most frequently applied radionuclides for the development of new radiotracers for positron emission tomography (PET) in the context of clinical cancer, neurological, and metabolic imaging. Until recently, the available radiochemical methodologies to introduce 18F into organic molecules ranging from small- to medium- and large-sized compounds were limited to a few applicable protocols. With the advent of late-stage fluorination of small aromatic, nonactivated compounds and various noncanonical labeling strategies geared toward the labeling of peptides and proteins, the molecular toolbox for PET radiotracer development was substantially extended. Especially, the noncanonical labeling methodologies characterized by the formation of Si–18F, B–18F, and Al–18F bonds give access to kit-like 18F-labeling of complex and side-group unprotected compounds, some of them already in clinical use. This chapter will particularly focus on silicon–fluoride acceptor (SiFA) chemistry and cover the history of its conceptual design and its translation into the clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wängler C, Kostikov A, Zhu J, Chin J, Wängler B, Schirrmacher R (2012) Silicon-[18F]fluorine radiochemistry: basics, applications and challenges. Appl Sci 2(2):277–302
Schirrmacher R, Bernard-Gauthier V, Schirrmacher E, Bailey JJ, Jurkschat K, Wängler C, Wängler B (2019) Silicon-based 18F-radiopharmaceuticals: from basic SiFA chemistry toward its clinical application. In: Fluorine in life sciences: pharmaceuticals, medicinal diagnostics, and agrochemicals progress in fluorine science series. Elsevier, pp 551–574
Bernard-Gauthier V, Lepage ML, Waengler B, Bailey JJ, Liang SH, Perrin DM, Vasdev N, Schirrmacher R (2018) Recent advances in 18F radiochemistry: a focus on B-18F, Si-18F, Al-18F, and C-18F radiofluorination via spirocyclic iodonium ylides. J Nucl Med 59(4):568–572
Jacobson O, Kiesewetter DO, Chen X (2015) Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug Chem 26(1):1–18
Mcbride WJ, D’Souza CA, Sharkey RM, Goldenberg DM (2012) The radiolabeling of proteins by the [18F]AlF method. Appl Radiat Isot 70(1):200–204
Laverman P, D’Souza CA, Eek A, Mcbride WJ, Sharkey RM, Oyen WJG, Goldenberg DM, Boerman OC (2012) Optimized labeling of NOTA-conjugated octreotide with F-18. Tumour Biol 33(2):427–434
Rosenthal MS, Bosch AL, Nickles RJ, Gatley SJ (1985) Synthesis and some characteristics of no-carrier added [18F]fluorotrimethylsilane. Int J Appl Radiat Isot 36(4):318–319
Ting R, Harwig CW, Lo J, Li Y, Adam MJ, Ruth TJ, Petrin DM (2008) Substituent effects on aryltrifluoroborate solvolysis in water: implications for Suzuki-Miyaura coupling and the design of stable 18F-labeled aryltrifluoroborates for use in PET imaging. J Org Chem 73(12):4662–4670
Ting R, Adam MJ, Ruth TJ, Perrin DM (2005) Arylfluoroborates and alkylfluorosilicates as potential PET imaging agents: high-yielding aqueous biomolecular 18F-labeling. J Am Chem Soc 127(38):13094–13095
Svoboda K (1985) Short review of specific activity phenomena. Phenomena dependent on specific activity but not changing it. J Radioanal Nucl Chem 88(1):13–29
Hevesy G (1923) The absorption and translocation of lead by plants: a contribution to the application of the method of radioactive indicators in the investigation of the change of substance in plants. Biochem J 17(4–5):439–445
Schirrmacher R, Bradtmöller G, Schirrmacher E, Thews O, Tillmanns J, Siessmeier T, Buchholz HG, Bartenstein P, Wängler B, Niemeyer CM (2006) 18F-labeling of peptides by means of an organosilicon-based fluoride acceptor. Angew Chem Int Ed 45(36):6047–6050. https://doi.org/10.1002/anie.200600795
Pauwels E, Cleeren F, Bormans G, Deroose CM, Leuven UZ (2018) Somatostatin receptor PET ligands – the next generation for clinical practice. Am J Nucl Med Mol Imaging 8(5):311–331
Waldmann CM, Stuparu AD, van Dam RM, Slavik R (2019) The search for an alternative to [68Ga]Ga-DOTA-TATE in neuroendocrine tumor theranostics: current state of 18F-labeled somatostatin analog development. Theranostics 9(5):1336–1347
Bernard-Gauthier V, Bailey JJ, Liu Z, Wängler B, Wängler C, Jurkschat K, Perrin DM, Schirrmacher R (2015) From unorthodox to established: the current status of 18F-trifluoroborate- and 18F-SiFA-based radiopharmaceuticals in PET nuclear imaging. Bioconjug Chem 27(2):267–279
Wängler C, Waser B, Alke A, Iovkova L, Buchholz H-G, Niedermoser S, Jurkschat K, Fottner C, Bartenstein P, Schirrmacher R, Reubi J-C, Wester H-J, Wängler B (2010) One-step 18F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET). Bioconjug Chem 21(12):2289–2296
Lindner S, Wängler C, Bailey JJ, Jurkschat K, Bartenstein P, Wängler B, Schirrmacher R (2020) Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography. Nat Protoc 15:3827–3843
Bernard-Gauthier V, Wängler C, Schirrmacher E, Kostikov A, Jurkschat K, Wängler B, Schirrmacher R (2014) 18F-labeled silicon-based fluoride acceptors: potential opportunities for novel positron emitting radiopharmaceuticals. Biomed Res Int 2014:454503
Niedermoser S, Chin J, Wängler C, Kostikov A, Bernard-Gauthier V, Vogler N, Soucy J-P, McEwan AJ, Schirrmacher R (2015) In vivo evaluation of 18F-SiFAlin-modified TATE: a potential challenge for 68Ga-DOTATATE, the clinical gold standard for somatostatin receptor imaging with PET. J Nucl Med 56(7):1100–1105
Ilhan H, Lindner S, Todica A, Cyran CC, Tiling R, Auernhammer CJ, Spitzweg C, Boeck S, Unterrainer M, Gildehaus FJ, Böning G, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Bartenstein P (2020) Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors. Eur J Nucl Med Mol Imaging 47(4):870–880
Unterrainer M, Lindner S, Beyer L, Gildehaus FJ, Todica A, Mittlmeier LM, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tonn JC, Albert NL, Bartenstein P, Ilhan H (2021) PET imaging of meningioma using the novel SSTR-targeting peptide 18F-SiTATE. Clin Nucl Med 46(8):667–668
Beyer L, Gosewisch A, Lindner S, Völter F, Mittelmeier LM, Tiling R, Brendel M, Cyran CC, Unterrainer M, Rübenthaler J, Auerhammer CJ, Spitzweg C, Böning G, Gildehaus FJ, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Wenter V, Todica A, Bartenstein P, Ilhan H (2021) Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 48(11):3571–3581
Lindner S, Simmet M, Gildehaus FJ, Jurkschat K, Wängler C, Wängler B, Bartenstein P, Schirrmacher R, Ilhan H (2020) Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors. Nucl Med Biol 88–89:86–95
Rosa-Neto P, Wängler B, Iovkova L, Boening G, Reader A, Jurkschat K, Schirrmacher E (2009) [18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins. Chembiochem 10:1321–1324
Glaser M, Iveson P, Hoppmann S, Indrevoll B, Wilson A, Arukwe J, Danikas A, Bhalla R, Hiscock D (2013) Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment. J Nucl Med 54(11):1981–1988
Hazari PP, Schulz J, Vimont D, Chadha N, Allard M, Szlosek-Pinaud M, Fouquet E, Mishra AK (2014) A new SiF-Dipropargyl glycerol scaffold as a versatile prosthetic group to design dimeric radioligands: synthesis of the [18F]BMPPSiF tracer to image serotonin receptors. ChemMedChem 9:337–349
Bohn P, Deyine A, Azzouz R, Bailly L, Fiol-Petit C, Bischoff L, Fruit C, Marsais F, Vera P (2009) Design of silicon-based misonidazole analogues and 18F-radiolabelling. Nucl Med Biol 36(8):895–905
Joyard Y, Azzouz R, Bischoff L, Papamicaël C, Labar D, Bol A, Bol V, Vera P, Grégoire V, Levacher V, Bohn P (2013) Synthesis of new 18F-radiolabeled silicon-based nitroimidazole compounds. Bioorg Med Chem 21(13):3680–3688
Zhu J, Chin J, Wängler C, Wängler B, Lennox RB, Schirrmacher R (2014) Rapid 18F-labeling and loading of PEGylated gold nanoparticles for in vivo applications. Bioconjug Chem 25:1143–1150
Wurzer A, Carlo D, Schmidt A, Beck R, Eiber M, Schwaiger M, Wester H-J (2020) Radiohybrid ligands: a novel tracer concept exemplified by 18F- or 68Ga-labeled RhPSMA inhibitors. J Nucl Med 61(5):735–742
Wurzer A, Carlo D, Herz M, Richter A, Robu S, Schirrmacher R, Mascarin A, Weber W, Eiber M, Schwaiger M, Wester H-J (2021) Automated synthesis of [18F]Ga-RhPSMA-7/-7.3: results, quality control and experience from more than 200 routine productions. EJNMMI Radiopharm Chem 6(41):4. https://doi.org/10.1186/s41181-021-00120-5
Connolly D, Bailey JJ, Ilhan H, Bartenstein P, Wangler C, Wangler B, Wuest F, Schirrmacher R (2020) 18F-labeling of radiotracers functionalized with a silicon fluoride acceptor (SiFA) for positron emission tomography. J Vis Exp 155:e60623. https://doi.org/10.3791/60623
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Gower-Fry, L. et al. (2024). Silicon–Fluoride Acceptors (SiFA) for 18F-Radiolabeling: From Bench to Bedside. In: Witney, T.H., Shuhendler, A.J. (eds) Positron Emission Tomography. Methods in Molecular Biology, vol 2729. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3499-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3499-8_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3498-1
Online ISBN: 978-1-0716-3499-8
eBook Packages: Springer Protocols